nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Gastrointestinal pain—Irinotecan—lung cancer	0.000428	0.000428	CcSEcCtD
Tobramycin—Dehydration—Doxorubicin—lung cancer	0.000427	0.000427	CcSEcCtD
Tobramycin—Anaphylactic shock—Paclitaxel—lung cancer	0.000427	0.000427	CcSEcCtD
Tobramycin—Paraesthesia—Cisplatin—lung cancer	0.000426	0.000426	CcSEcCtD
Tobramycin—Thrombocytopenia—Etoposide—lung cancer	0.000426	0.000426	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Methotrexate—lung cancer	0.000426	0.000426	CcSEcCtD
Tobramycin—Dyspnoea—Cisplatin—lung cancer	0.000423	0.000423	CcSEcCtD
Tobramycin—Skin disorder—Etoposide—lung cancer	0.000423	0.000423	CcSEcCtD
Tobramycin—Dry skin—Doxorubicin—lung cancer	0.000421	0.000421	CcSEcCtD
Tobramycin—Feeling abnormal—Gemcitabine—lung cancer	0.00042	0.00042	CcSEcCtD
Tobramycin—Dizziness—Vinorelbine—lung cancer	0.000419	0.000419	CcSEcCtD
Tobramycin—Nervous system disorder—Paclitaxel—lung cancer	0.000418	0.000418	CcSEcCtD
Tobramycin—Hypokalaemia—Doxorubicin—lung cancer	0.000418	0.000418	CcSEcCtD
Tobramycin—Thrombocytopenia—Paclitaxel—lung cancer	0.000418	0.000418	CcSEcCtD
Tobramycin—Anorexia—Etoposide—lung cancer	0.000415	0.000415	CcSEcCtD
Tobramycin—Skin disorder—Paclitaxel—lung cancer	0.000414	0.000414	CcSEcCtD
Tobramycin—Abdominal pain—Irinotecan—lung cancer	0.000414	0.000414	CcSEcCtD
Tobramycin—Body temperature increased—Irinotecan—lung cancer	0.000414	0.000414	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000413	0.000413	CcSEcCtD
Tobramycin—Decreased appetite—Cisplatin—lung cancer	0.000413	0.000413	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Cisplatin—lung cancer	0.00041	0.00041	CcSEcCtD
Tobramycin—Anaemia—Docetaxel—lung cancer	0.00041	0.00041	CcSEcCtD
Tobramycin—Infestation NOS—Methotrexate—lung cancer	0.000409	0.000409	CcSEcCtD
Tobramycin—Infestation—Methotrexate—lung cancer	0.000409	0.000409	CcSEcCtD
Tobramycin—Anorexia—Paclitaxel—lung cancer	0.000407	0.000407	CcSEcCtD
Tobramycin—Pain—Cisplatin—lung cancer	0.000406	0.000406	CcSEcCtD
Tobramycin—Muscular weakness—Doxorubicin—lung cancer	0.000405	0.000405	CcSEcCtD
Tobramycin—Vomiting—Vinorelbine—lung cancer	0.000403	0.000403	CcSEcCtD
Tobramycin—Body temperature increased—Gemcitabine—lung cancer	0.000403	0.000403	CcSEcCtD
Tobramycin—Renal failure—Methotrexate—lung cancer	0.000402	0.000402	CcSEcCtD
Tobramycin—Rash—Vinorelbine—lung cancer	0.0004	0.0004	CcSEcCtD
Tobramycin—Dermatitis—Vinorelbine—lung cancer	0.0004	0.0004	CcSEcCtD
Tobramycin—Stomatitis—Methotrexate—lung cancer	0.000398	0.000398	CcSEcCtD
Tobramycin—Headache—Vinorelbine—lung cancer	0.000397	0.000397	CcSEcCtD
Tobramycin—Asthma—Doxorubicin—lung cancer	0.000397	0.000397	CcSEcCtD
Tobramycin—Leukopenia—Docetaxel—lung cancer	0.000397	0.000397	CcSEcCtD
Tobramycin—Eosinophilia—Doxorubicin—lung cancer	0.000393	0.000393	CcSEcCtD
Tobramycin—Feeling abnormal—Cisplatin—lung cancer	0.000391	0.000391	CcSEcCtD
Tobramycin—Paraesthesia—Etoposide—lung cancer	0.000391	0.000391	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000389	0.000389	CcSEcCtD
Tobramycin—Dyspnoea—Etoposide—lung cancer	0.000388	0.000388	CcSEcCtD
Tobramycin—Cough—Docetaxel—lung cancer	0.000387	0.000387	CcSEcCtD
Tobramycin—Epistaxis—Methotrexate—lung cancer	0.000385	0.000385	CcSEcCtD
Tobramycin—Hypersensitivity—Irinotecan—lung cancer	0.000385	0.000385	CcSEcCtD
Tobramycin—Paraesthesia—Paclitaxel—lung cancer	0.000383	0.000383	CcSEcCtD
Tobramycin—Bronchitis—Doxorubicin—lung cancer	0.000382	0.000382	CcSEcCtD
Tobramycin—Agranulocytosis—Methotrexate—lung cancer	0.000381	0.000381	CcSEcCtD
Tobramycin—Dyspnoea—Paclitaxel—lung cancer	0.00038	0.00038	CcSEcCtD
Tobramycin—Decreased appetite—Etoposide—lung cancer	0.000378	0.000378	CcSEcCtD
Tobramycin—Myalgia—Docetaxel—lung cancer	0.000377	0.000377	CcSEcCtD
Tobramycin—Chest pain—Docetaxel—lung cancer	0.000377	0.000377	CcSEcCtD
Tobramycin—Nausea—Vinorelbine—lung cancer	0.000377	0.000377	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Etoposide—lung cancer	0.000376	0.000376	CcSEcCtD
Tobramycin—Body temperature increased—Cisplatin—lung cancer	0.000375	0.000375	CcSEcCtD
Tobramycin—Asthenia—Irinotecan—lung cancer	0.000375	0.000375	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000375	0.000375	CcSEcCtD
Tobramycin—Pain—Etoposide—lung cancer	0.000372	0.000372	CcSEcCtD
Tobramycin—Decreased appetite—Paclitaxel—lung cancer	0.000371	0.000371	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000369	0.000369	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000368	0.000368	CcSEcCtD
Tobramycin—Asthenia—Gemcitabine—lung cancer	0.000366	0.000366	CcSEcCtD
Tobramycin—Pain—Paclitaxel—lung cancer	0.000365	0.000365	CcSEcCtD
Tobramycin—Confusional state—Docetaxel—lung cancer	0.000365	0.000365	CcSEcCtD
Tobramycin—Pharyngitis—Methotrexate—lung cancer	0.000364	0.000364	CcSEcCtD
Tobramycin—Urinary tract disorder—Methotrexate—lung cancer	0.000362	0.000362	CcSEcCtD
Tobramycin—Anaphylactic shock—Docetaxel—lung cancer	0.000362	0.000362	CcSEcCtD
Tobramycin—Pruritus—Gemcitabine—lung cancer	0.000361	0.000361	CcSEcCtD
Tobramycin—Urethral disorder—Methotrexate—lung cancer	0.00036	0.00036	CcSEcCtD
Tobramycin—Weight decreased—Doxorubicin—lung cancer	0.000359	0.000359	CcSEcCtD
Tobramycin—Feeling abnormal—Etoposide—lung cancer	0.000359	0.000359	CcSEcCtD
Tobramycin—Diarrhoea—Irinotecan—lung cancer	0.000358	0.000358	CcSEcCtD
Tobramycin—Gastrointestinal pain—Etoposide—lung cancer	0.000356	0.000356	CcSEcCtD
Tobramycin—Nervous system disorder—Docetaxel—lung cancer	0.000355	0.000355	CcSEcCtD
Tobramycin—Thrombocytopenia—Docetaxel—lung cancer	0.000354	0.000354	CcSEcCtD
Tobramycin—Infestation—Doxorubicin—lung cancer	0.000354	0.000354	CcSEcCtD
Tobramycin—Infestation NOS—Doxorubicin—lung cancer	0.000354	0.000354	CcSEcCtD
Tobramycin—Visual impairment—Methotrexate—lung cancer	0.000354	0.000354	CcSEcCtD
Tobramycin—Feeling abnormal—Paclitaxel—lung cancer	0.000352	0.000352	CcSEcCtD
Tobramycin—Skin disorder—Docetaxel—lung cancer	0.000351	0.000351	CcSEcCtD
Tobramycin—Hypersensitivity—Cisplatin—lung cancer	0.00035	0.00035	CcSEcCtD
Tobramycin—Gastrointestinal pain—Paclitaxel—lung cancer	0.000349	0.000349	CcSEcCtD
Tobramycin—Diarrhoea—Gemcitabine—lung cancer	0.000349	0.000349	CcSEcCtD
Tobramycin—Renal failure—Doxorubicin—lung cancer	0.000348	0.000348	CcSEcCtD
Tobramycin—Neuropathy peripheral—Doxorubicin—lung cancer	0.000347	0.000347	CcSEcCtD
Tobramycin—Dizziness—Irinotecan—lung cancer	0.000346	0.000346	CcSEcCtD
Tobramycin—Urticaria—Etoposide—lung cancer	0.000346	0.000346	CcSEcCtD
Tobramycin—Stomatitis—Doxorubicin—lung cancer	0.000345	0.000345	CcSEcCtD
Tobramycin—Anorexia—Docetaxel—lung cancer	0.000345	0.000345	CcSEcCtD
Tobramycin—Abdominal pain—Etoposide—lung cancer	0.000344	0.000344	CcSEcCtD
Tobramycin—Body temperature increased—Etoposide—lung cancer	0.000344	0.000344	CcSEcCtD
Tobramycin—Eye disorder—Methotrexate—lung cancer	0.000343	0.000343	CcSEcCtD
Tobramycin—Tinnitus—Methotrexate—lung cancer	0.000342	0.000342	CcSEcCtD
Tobramycin—Asthenia—Cisplatin—lung cancer	0.000341	0.000341	CcSEcCtD
Tobramycin—Urticaria—Paclitaxel—lung cancer	0.000339	0.000339	CcSEcCtD
Tobramycin—Abdominal pain—Paclitaxel—lung cancer	0.000337	0.000337	CcSEcCtD
Tobramycin—Body temperature increased—Paclitaxel—lung cancer	0.000337	0.000337	CcSEcCtD
Tobramycin—Epistaxis—Doxorubicin—lung cancer	0.000334	0.000334	CcSEcCtD
Tobramycin—Angiopathy—Methotrexate—lung cancer	0.000333	0.000333	CcSEcCtD
Tobramycin—Vomiting—Irinotecan—lung cancer	0.000333	0.000333	CcSEcCtD
Tobramycin—Sinusitis—Doxorubicin—lung cancer	0.000332	0.000332	CcSEcCtD
Tobramycin—Immune system disorder—Methotrexate—lung cancer	0.000331	0.000331	CcSEcCtD
Tobramycin—Mediastinal disorder—Methotrexate—lung cancer	0.000331	0.000331	CcSEcCtD
Tobramycin—Agranulocytosis—Doxorubicin—lung cancer	0.00033	0.00033	CcSEcCtD
Tobramycin—Rash—Irinotecan—lung cancer	0.00033	0.00033	CcSEcCtD
Tobramycin—Dermatitis—Irinotecan—lung cancer	0.00033	0.00033	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000329	0.000329	CcSEcCtD
Tobramycin—Headache—Irinotecan—lung cancer	0.000328	0.000328	CcSEcCtD
Tobramycin—Diarrhoea—Cisplatin—lung cancer	0.000325	0.000325	CcSEcCtD
Tobramycin—Paraesthesia—Docetaxel—lung cancer	0.000325	0.000325	CcSEcCtD
Tobramycin—Vomiting—Gemcitabine—lung cancer	0.000324	0.000324	CcSEcCtD
Tobramycin—Dyspnoea—Docetaxel—lung cancer	0.000322	0.000322	CcSEcCtD
Tobramycin—Rash—Gemcitabine—lung cancer	0.000321	0.000321	CcSEcCtD
Tobramycin—Dermatitis—Gemcitabine—lung cancer	0.000321	0.000321	CcSEcCtD
Tobramycin—Hypersensitivity—Etoposide—lung cancer	0.000321	0.000321	CcSEcCtD
Tobramycin—Erythema—Methotrexate—lung cancer	0.000319	0.000319	CcSEcCtD
Tobramycin—Headache—Gemcitabine—lung cancer	0.000319	0.000319	CcSEcCtD
Tobramycin—Rhinitis—Doxorubicin—lung cancer	0.000318	0.000318	CcSEcCtD
Tobramycin—Pharyngitis—Doxorubicin—lung cancer	0.000315	0.000315	CcSEcCtD
Tobramycin—Decreased appetite—Docetaxel—lung cancer	0.000314	0.000314	CcSEcCtD
Tobramycin—Hypersensitivity—Paclitaxel—lung cancer	0.000314	0.000314	CcSEcCtD
Tobramycin—Urinary tract disorder—Doxorubicin—lung cancer	0.000314	0.000314	CcSEcCtD
Tobramycin—Dysgeusia—Methotrexate—lung cancer	0.000313	0.000313	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Docetaxel—lung cancer	0.000312	0.000312	CcSEcCtD
Tobramycin—Asthenia—Etoposide—lung cancer	0.000312	0.000312	CcSEcCtD
Tobramycin—Connective tissue disorder—Doxorubicin—lung cancer	0.000312	0.000312	CcSEcCtD
Tobramycin—Urethral disorder—Doxorubicin—lung cancer	0.000311	0.000311	CcSEcCtD
Tobramycin—Nausea—Irinotecan—lung cancer	0.000311	0.000311	CcSEcCtD
Tobramycin—Pain—Docetaxel—lung cancer	0.000309	0.000309	CcSEcCtD
Tobramycin—Back pain—Methotrexate—lung cancer	0.000309	0.000309	CcSEcCtD
Tobramycin—Pruritus—Etoposide—lung cancer	0.000308	0.000308	CcSEcCtD
Tobramycin—Visual impairment—Doxorubicin—lung cancer	0.000306	0.000306	CcSEcCtD
Tobramycin—Asthenia—Paclitaxel—lung cancer	0.000306	0.000306	CcSEcCtD
Tobramycin—Nausea—Gemcitabine—lung cancer	0.000303	0.000303	CcSEcCtD
Tobramycin—Vomiting—Cisplatin—lung cancer	0.000302	0.000302	CcSEcCtD
Tobramycin—Pruritus—Paclitaxel—lung cancer	0.000302	0.000302	CcSEcCtD
Tobramycin—Vision blurred—Methotrexate—lung cancer	0.000301	0.000301	CcSEcCtD
Tobramycin—Rash—Cisplatin—lung cancer	0.000299	0.000299	CcSEcCtD
Tobramycin—Dermatitis—Cisplatin—lung cancer	0.000299	0.000299	CcSEcCtD
Tobramycin—Feeling abnormal—Docetaxel—lung cancer	0.000298	0.000298	CcSEcCtD
Tobramycin—Diarrhoea—Etoposide—lung cancer	0.000298	0.000298	CcSEcCtD
Tobramycin—Eye disorder—Doxorubicin—lung cancer	0.000297	0.000297	CcSEcCtD
Tobramycin—Ill-defined disorder—Methotrexate—lung cancer	0.000296	0.000296	CcSEcCtD
Tobramycin—Tinnitus—Doxorubicin—lung cancer	0.000296	0.000296	CcSEcCtD
Tobramycin—Gastrointestinal pain—Docetaxel—lung cancer	0.000296	0.000296	CcSEcCtD
Tobramycin—Anaemia—Methotrexate—lung cancer	0.000295	0.000295	CcSEcCtD
Tobramycin—Diarrhoea—Paclitaxel—lung cancer	0.000292	0.000292	CcSEcCtD
Tobramycin—Angiopathy—Doxorubicin—lung cancer	0.000288	0.000288	CcSEcCtD
Tobramycin—Malaise—Methotrexate—lung cancer	0.000288	0.000288	CcSEcCtD
Tobramycin—Dizziness—Etoposide—lung cancer	0.000288	0.000288	CcSEcCtD
Tobramycin—Immune system disorder—Doxorubicin—lung cancer	0.000287	0.000287	CcSEcCtD
Tobramycin—Vertigo—Methotrexate—lung cancer	0.000287	0.000287	CcSEcCtD
Tobramycin—Mediastinal disorder—Doxorubicin—lung cancer	0.000286	0.000286	CcSEcCtD
Tobramycin—Body temperature increased—Docetaxel—lung cancer	0.000286	0.000286	CcSEcCtD
Tobramycin—Abdominal pain—Docetaxel—lung cancer	0.000286	0.000286	CcSEcCtD
Tobramycin—Leukopenia—Methotrexate—lung cancer	0.000286	0.000286	CcSEcCtD
Tobramycin—Dizziness—Paclitaxel—lung cancer	0.000282	0.000282	CcSEcCtD
Tobramycin—Nausea—Cisplatin—lung cancer	0.000282	0.000282	CcSEcCtD
Tobramycin—Cough—Methotrexate—lung cancer	0.000279	0.000279	CcSEcCtD
Tobramycin—Vomiting—Etoposide—lung cancer	0.000277	0.000277	CcSEcCtD
Tobramycin—Erythema—Doxorubicin—lung cancer	0.000277	0.000277	CcSEcCtD
Tobramycin—Rash—Etoposide—lung cancer	0.000274	0.000274	CcSEcCtD
Tobramycin—Dermatitis—Etoposide—lung cancer	0.000274	0.000274	CcSEcCtD
Tobramycin—Headache—Etoposide—lung cancer	0.000273	0.000273	CcSEcCtD
Tobramycin—Chest pain—Methotrexate—lung cancer	0.000272	0.000272	CcSEcCtD
Tobramycin—Myalgia—Methotrexate—lung cancer	0.000272	0.000272	CcSEcCtD
Tobramycin—Vomiting—Paclitaxel—lung cancer	0.000271	0.000271	CcSEcCtD
Tobramycin—Dysgeusia—Doxorubicin—lung cancer	0.000271	0.000271	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.00027	0.00027	CcSEcCtD
Tobramycin—Rash—Paclitaxel—lung cancer	0.000269	0.000269	CcSEcCtD
Tobramycin—Dermatitis—Paclitaxel—lung cancer	0.000269	0.000269	CcSEcCtD
Tobramycin—Discomfort—Methotrexate—lung cancer	0.000269	0.000269	CcSEcCtD
Tobramycin—Back pain—Doxorubicin—lung cancer	0.000267	0.000267	CcSEcCtD
Tobramycin—Headache—Paclitaxel—lung cancer	0.000267	0.000267	CcSEcCtD
Tobramycin—Hypersensitivity—Docetaxel—lung cancer	0.000266	0.000266	CcSEcCtD
Tobramycin—Confusional state—Methotrexate—lung cancer	0.000263	0.000263	CcSEcCtD
Tobramycin—Anaphylactic shock—Methotrexate—lung cancer	0.000261	0.000261	CcSEcCtD
Tobramycin—Vision blurred—Doxorubicin—lung cancer	0.000261	0.000261	CcSEcCtD
Tobramycin—Asthenia—Docetaxel—lung cancer	0.000259	0.000259	CcSEcCtD
Tobramycin—Nausea—Etoposide—lung cancer	0.000258	0.000258	CcSEcCtD
Tobramycin—Ill-defined disorder—Doxorubicin—lung cancer	0.000257	0.000257	CcSEcCtD
Tobramycin—Pruritus—Docetaxel—lung cancer	0.000256	0.000256	CcSEcCtD
Tobramycin—Nervous system disorder—Methotrexate—lung cancer	0.000256	0.000256	CcSEcCtD
Tobramycin—Anaemia—Doxorubicin—lung cancer	0.000256	0.000256	CcSEcCtD
Tobramycin—Thrombocytopenia—Methotrexate—lung cancer	0.000255	0.000255	CcSEcCtD
Tobramycin—Nausea—Paclitaxel—lung cancer	0.000253	0.000253	CcSEcCtD
Tobramycin—Skin disorder—Methotrexate—lung cancer	0.000253	0.000253	CcSEcCtD
Tobramycin—Malaise—Doxorubicin—lung cancer	0.000249	0.000249	CcSEcCtD
Tobramycin—Vertigo—Doxorubicin—lung cancer	0.000248	0.000248	CcSEcCtD
Tobramycin—Anorexia—Methotrexate—lung cancer	0.000248	0.000248	CcSEcCtD
Tobramycin—Leukopenia—Doxorubicin—lung cancer	0.000248	0.000248	CcSEcCtD
Tobramycin—Diarrhoea—Docetaxel—lung cancer	0.000247	0.000247	CcSEcCtD
Tobramycin—Cough—Doxorubicin—lung cancer	0.000241	0.000241	CcSEcCtD
Tobramycin—Dizziness—Docetaxel—lung cancer	0.000239	0.000239	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000237	0.000237	CcSEcCtD
Tobramycin—Chest pain—Doxorubicin—lung cancer	0.000235	0.000235	CcSEcCtD
Tobramycin—Myalgia—Doxorubicin—lung cancer	0.000235	0.000235	CcSEcCtD
Tobramycin—Paraesthesia—Methotrexate—lung cancer	0.000234	0.000234	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000234	0.000234	CcSEcCtD
Tobramycin—Discomfort—Doxorubicin—lung cancer	0.000233	0.000233	CcSEcCtD
Tobramycin—Dyspnoea—Methotrexate—lung cancer	0.000232	0.000232	CcSEcCtD
Tobramycin—Vomiting—Docetaxel—lung cancer	0.00023	0.00023	CcSEcCtD
Tobramycin—Rash—Docetaxel—lung cancer	0.000228	0.000228	CcSEcCtD
Tobramycin—Dermatitis—Docetaxel—lung cancer	0.000228	0.000228	CcSEcCtD
Tobramycin—Confusional state—Doxorubicin—lung cancer	0.000228	0.000228	CcSEcCtD
Tobramycin—Decreased appetite—Methotrexate—lung cancer	0.000227	0.000227	CcSEcCtD
Tobramycin—Headache—Docetaxel—lung cancer	0.000227	0.000227	CcSEcCtD
Tobramycin—Anaphylactic shock—Doxorubicin—lung cancer	0.000226	0.000226	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Methotrexate—lung cancer	0.000225	0.000225	CcSEcCtD
Tobramycin—Pain—Methotrexate—lung cancer	0.000223	0.000223	CcSEcCtD
Tobramycin—Nervous system disorder—Doxorubicin—lung cancer	0.000221	0.000221	CcSEcCtD
Tobramycin—Thrombocytopenia—Doxorubicin—lung cancer	0.000221	0.000221	CcSEcCtD
Tobramycin—Skin disorder—Doxorubicin—lung cancer	0.000219	0.000219	CcSEcCtD
Tobramycin—Anorexia—Doxorubicin—lung cancer	0.000215	0.000215	CcSEcCtD
Tobramycin—Nausea—Docetaxel—lung cancer	0.000215	0.000215	CcSEcCtD
Tobramycin—Feeling abnormal—Methotrexate—lung cancer	0.000215	0.000215	CcSEcCtD
Tobramycin—Gastrointestinal pain—Methotrexate—lung cancer	0.000213	0.000213	CcSEcCtD
Tobramycin—Urticaria—Methotrexate—lung cancer	0.000207	0.000207	CcSEcCtD
Tobramycin—Body temperature increased—Methotrexate—lung cancer	0.000206	0.000206	CcSEcCtD
Tobramycin—Abdominal pain—Methotrexate—lung cancer	0.000206	0.000206	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000206	0.000206	CcSEcCtD
Tobramycin—Paraesthesia—Doxorubicin—lung cancer	0.000203	0.000203	CcSEcCtD
Tobramycin—Dyspnoea—Doxorubicin—lung cancer	0.000201	0.000201	CcSEcCtD
Tobramycin—Decreased appetite—Doxorubicin—lung cancer	0.000196	0.000196	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000195	0.000195	CcSEcCtD
Tobramycin—Pain—Doxorubicin—lung cancer	0.000193	0.000193	CcSEcCtD
Tobramycin—Hypersensitivity—Methotrexate—lung cancer	0.000192	0.000192	CcSEcCtD
Tobramycin—Asthenia—Methotrexate—lung cancer	0.000187	0.000187	CcSEcCtD
Tobramycin—Feeling abnormal—Doxorubicin—lung cancer	0.000186	0.000186	CcSEcCtD
Tobramycin—Gastrointestinal pain—Doxorubicin—lung cancer	0.000185	0.000185	CcSEcCtD
Tobramycin—Pruritus—Methotrexate—lung cancer	0.000184	0.000184	CcSEcCtD
Tobramycin—Urticaria—Doxorubicin—lung cancer	0.000179	0.000179	CcSEcCtD
Tobramycin—Abdominal pain—Doxorubicin—lung cancer	0.000178	0.000178	CcSEcCtD
Tobramycin—Body temperature increased—Doxorubicin—lung cancer	0.000178	0.000178	CcSEcCtD
Tobramycin—Diarrhoea—Methotrexate—lung cancer	0.000178	0.000178	CcSEcCtD
Tobramycin—Dizziness—Methotrexate—lung cancer	0.000172	0.000172	CcSEcCtD
Tobramycin—Hypersensitivity—Doxorubicin—lung cancer	0.000166	0.000166	CcSEcCtD
Tobramycin—Vomiting—Methotrexate—lung cancer	0.000166	0.000166	CcSEcCtD
Tobramycin—Rash—Methotrexate—lung cancer	0.000164	0.000164	CcSEcCtD
Tobramycin—Dermatitis—Methotrexate—lung cancer	0.000164	0.000164	CcSEcCtD
Tobramycin—Headache—Methotrexate—lung cancer	0.000163	0.000163	CcSEcCtD
Tobramycin—Asthenia—Doxorubicin—lung cancer	0.000162	0.000162	CcSEcCtD
Tobramycin—Pruritus—Doxorubicin—lung cancer	0.00016	0.00016	CcSEcCtD
Tobramycin—Nausea—Methotrexate—lung cancer	0.000155	0.000155	CcSEcCtD
Tobramycin—Diarrhoea—Doxorubicin—lung cancer	0.000154	0.000154	CcSEcCtD
Tobramycin—Dizziness—Doxorubicin—lung cancer	0.000149	0.000149	CcSEcCtD
Tobramycin—Vomiting—Doxorubicin—lung cancer	0.000143	0.000143	CcSEcCtD
Tobramycin—Rash—Doxorubicin—lung cancer	0.000142	0.000142	CcSEcCtD
Tobramycin—Dermatitis—Doxorubicin—lung cancer	0.000142	0.000142	CcSEcCtD
Tobramycin—Headache—Doxorubicin—lung cancer	0.000141	0.000141	CcSEcCtD
Tobramycin—Nausea—Doxorubicin—lung cancer	0.000134	0.000134	CcSEcCtD
